VASCULAR PHARMACOLOGY
期刊信息导读
- VASCULAR PHARMACOLOGY基本信息
- VASCULAR PHARMACOLOGY中科院SCI期刊分区
- 历年VASCULAR PHARMACOLOGY影响因子趋势图
- VASCULAR PHARMACOLOGY期刊英文简介
- VASCULAR PHARMACOLOGY期刊中文简介
VASCULAR PHARMACOLOGY基本信息
简称:VASC PHARMACOL
中文名称:血管药理学
研究方向:医学
2018-2019最新影响因子:3.33
SCI类别:SCI/SCIE
是否OA开放访问:No
出版地:UNITED STATES
出版周期:Monthly
创刊年份:2002
年文章数:49
涉及的研究方向:医学-药学
通讯方式:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
官方网站:http://www.journals.elsevier.com/vascular-pharmacology/
投稿网址:http://www.evise.com/evise/faces/pages/navigation/NavController.jspx?JRNL_ACR=VPH
审稿速度:较慢,6-12周
平均录用比例:一般
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1537-1891%5BISSN%5D
VASCULAR PHARMACOLOGY期刊英文简介
Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English.The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.
VASCULAR PHARMACOLOGY期刊中文简介
血管药理学发表论文,包含血管系统生物学和药理学各方面的结果。鼓励在血管生物学和药理学的基础、转化和临床方面使用从分子生物学到综合生理学的方法发表论文。所有论文都是英文的。该杂志发表评论文章,其中包括血管方面的血栓形成,炎症,细胞信号,动脉粥样硬化和脂质代谢。对作者的好处我们还提供许多作者利益,例如免费的PDF、自由的版权政策、爱思唯尔出版物的特别折扣等等。有关作者服务的详细信息,请单击此处。有关文章提交的信息,请参阅我们的作者指南。如果您需要更多信息或帮助,请访问我们的支持中心。
中科院SCI期刊分区:
VASCULAR PHARMACOLOGY影响因子
获取相关优质资源获取2023中科院分区